Genetic enrichment of cardiomyocytes derived frommouse embryonic stem cells

African Journal of Biotechnology

Volumn 10, Issue 29, 2011, Pages 5683-5691

  He, Wen Jun ^a,b   Li, Shi Chong ^a   Ye, Ling Ling ^a   Liu, Hong ^a   Wang, Qi Wei ^a   Han, Wei Dong ^b   Fu, Xiao Bing ^b   Chen, Zhao Lie ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

myosin heavy chain promoter; Cardiomyocytes; Differentiation; Embryonic stem cells; Geneticenrichment

Indexed keywords

ALPHA ACTIN; HYGROMYCIN; MYOSIN HEAVY CHAIN ALPHA; NEOMYCIN;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL LINE; CELL SELECTION; CELL STRUCTURE; CONTROLLED STUDY; CYTOLOGY; EMBRYO; EMBRYONIC STEM CELL; GENETIC MANIPULATION; GENETIC TRANSFECTION; HEART MUSCLE CELL; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; SIMIAN VIRUS 40; TRANSGENICS;

EID: 79959750389     PISSN: 16845315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Anderson D, Self T, Mellor IR, Goh G, Hill SJ, Denning C (2007).Transgenic enrichment of cardiomyocytes from human embryonicstem cells. Mol. Ther. 15: 2027-2036.
2. Byrne JA, Pedersen DA, Clepper LL, Nelson M, Sanger WG, Gokhale S, Wolf DP, Mitalipov SM. (2007). Producing primate embryonic stemcells by somatic cell nuclear transfer. Nature, 450: 497-502.
3. David R, Theiss H, Franz WM (2008). Connexin 40 promoter-basedenrichment of embryonic stem cell-derived cardiovascular progenitorcells. Cells Tiss, Organs, 188: 62-69.
4. Delcayre C, Swynghedauw B (2002). Molecular mechanisms ofmyocardial remodeling. J. Mol. Cell Cardiol. 34: 1577-1584.
5. Dimmeler S, Zeiher AM, Schneider MD (2005). Unchain my heart: thescientific foundations of cardiac repair. J. Clin. Invest. 115: 572-583.
6. Doetschman TC, Eistetter H, Katz M, Schmidt W, Kemler R (1985). Thein vitro development of blastocyst-derived embryonic stem cell lines:formation of visceral yolk sac, blood islands and myocardium. J.Embryol. Exp. Morphol. 87: 27-45.
7. Fijnvandraat AC, van Ginneken AC, Schumacher CA, Boheler KR, Lekanne Deprez RH, Christoffels VM, Moorman AF (2003).Cardiomyocytes purified from differentiated embryonic stem cellsexhibit characteristics of early chamber myocardium. J. Mol. CellCardiol. 35: 1461-1472.
8. Gepstein L (2002). Derivation and potential applications of humanembryonic stem cells. Circ. Res. 91: 866-876.
9. Gulick J, Subramaniam A, Neumann J, Robbins J (1991). Isolation andcharacterization of the mouse cardiac myosin heavy chain genes. J.Biol. Chem. 266: 9180-9185.
10. He WJ, Li SC, Ye LL, Wang QW, Wang HT, Xie J, Liu H, Chen ZL(2009). Construction and characterization of cardiac specificbpromoter-driven expression vector. Sheng Wu Gong Cheng XueBao. 25: 1546-1551.
11. Hristov M, Weber C (2006). The therapeutic potential of progenitor cellsin ischemic heart disease--Past, present and future. Basic Res.Cardiol. 101: 1-7.
12. Huber I, Itzhaki I, Caspi O, Arbel G, Tzukerman M, Gepstein A, Habib M, Yankelson L, Kehat I, Gepstein L (2007). Identification andselection of cardiomyocytes during human embryonic stem celldifferentiation. FASEB J. 21: 2551-2563.
13. Klug MG, Soonpaa MH, Koh GY, Field LJ (1996). Genetically selectedcardiomyocytes from differentiating embronic stem cells form stableintracardiac grafts. J. Clin. Invest. 98: 216-224.
14. Kolossov E, Fleischmann BK, Liu Q, Bloch W, Viatchenko-Karpinski S, Manzke O, Ji GJ, Bohlen H, Addicks K, Hescheler J (1998).Functional characteristics of ES cell-derived cardiac precursor cellsidentified by tissue-specific expression of the green fluorescentprotein. J. Cell Biol. 143: 2045-2056.
15. Kolossov E, Lu Z, Drobinskaya I, Gassanov N, Duan Y, Sauer H, Manzke O, Bloch W, Bohlen H, Hescheler J, Fleischmann BK (2005).Identification and characterization of embryonic stem cell-derivedpacemaker and atrial cardiomyocytes. FASEB J. 19: 577-579.
16. Laflamme MA, Murry CE (2005). Regenerating the heart. Nat.Biotechnol. 23: 845-856.
17. Liew CC, Jandreski MA (1986). Construction and characterization of thealpha form of a cardiac myosin heavy chain cDNA clone and itsdevelopmental expression in the Syrian hamster. Proc. Natl. Acad.Sci. USA., 83: 3175-3179.
18. Menasché P (2008). Skeletal myoblasts and cardiac repair. J. Mol. CellCardiol. 45: 545-553.
19. Müller M, Fleischmann BK, Selbert S, Ji GJ, Endl E, Middeler G, Müller OJ, Schlenke P, Frese S, Wobus AM, Hescheler J, Katus HA, Franz WM (2000). Selection of ventricular-like cardiomyocytes from EScells in vitro. FASEB J. 14: 2540-2548.
20. Segev H, Kenyagin-Karsenti D, Fishman B, Gerecht-Nir S, Ziskind A, Amit M, Coleman R, Itskovitz-Eldor J (2005). Molecular analysis ofcardiomyocytes derived from human embryonic stem cells. Dev.Growth Differ. 47: 295-306.
21. Xu C, Police S, Rao N, Carpenter MK (2002). Characterization andenrichment of cardiomyocytes derived from human embryonic stemcells. Circ. Res. 91: 501-508.
22. Yang L, Soonpaa MH, Adler ED, Roepke TK, Kattman SJ, Kennedy M, Henckaerts E, Bonham K, Abbott GW, Linden RM, Field LJ, Keller GM (2008). Human cardiovascular progenitor cells develop from aKDR+ embryonic-stem-cell-derived population. Nature, 453: 524-528.
23. Ye L, Haider HKh, Sim EK (2006). Adult stem cells for cardiac repair: achoice between skeletal myoblasts and bone marrow stem cells. Exp.Biol. Med. (Maywood). 231: 8-19.
24. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA (2007). Induced pluripotent stem cell lines derived from humansomatic cells. Science, 318: 1917-1920.
25. Zimmermann WH, Eschenhagen T (2007). Embryonic stem cells forcardiac muscle engineering. Trends Cardiovasc. Med. 17: 134-140.